Research Hypothesis Essay

Null Hypothesis The new veritable drug has no hefty difference from the bar multi-drug regimen engrossd by most malignant neoplastic disease patients (1 = 2).Alternative Hypothesis The new developed drug is good better from the standard multi-drug regimen used by most crabby person patients (1 2).The dependent inconstant in the study is the so-called level of efficacy (or in simple term, the level of effectiveness of the drug). This independent covariant may be measured by 1) T-cell counts among AIDS patients, 2) improved transmission line circulation (measured by blood pumped per ounce per second), and 3) rate of antibody formation. For the sake of simplicity, we shall besides consider the first measure of efficacy (T-cell counts among AIDS patients). The independent variable in the study is the type of drug used to treat patients with AIDS. mannerFor the purpose of theoretical efficiency, we can assume the existence of two groups. free radical A is a world sample treat ed with the new developed drug. Group B is a population sample treated with the standard multi-drug regimen. Note that both drugs atomic number 18 assumed to have a global effect on the mitigation of AIDS among patients. A higher population mean (measured by T-cell counts) would indicate a higher level of efficacy.BiasesExperimenter stoop may be exhibited in the study as 1) error in the specification of experimental maneuver, 2) error in the measurement of outcomes, and 3) faulty translation of data. Because of the complexity of the study, it is very likely for the researcher to commit the second error. picking bias is not present in the study.Ethical IssuesThere are two pressing ethical issues in the study. First, it is generally unethical to use an un leavened drug (medical) to a group of AIDS patients (although it may be argued that the drug has been tested many times in the laboratory). Second, it is dangerous to test the efficacy of two sets of drugs to actual patients.